Human C-telopeptide of type 2 collagen,CTX-2 ELISA Kit

Contact us for 48 wells and bulk quote

Introducing the HUMAN C-TELOPEPTIDE OF TYPE 2 COLLAGEN, CTX-2 ELISA KIT, a cutting-edge solution designed to accurately measure the levels of CTX-2 in human samples. This advanced kit utilizes the Enzyme-Linked Immunosorbent Assay (ELISA) technique, renowned for its high sensitivity and specificity, ensuring precise and reliable results.

The HUMAN C-TELOPEPTIDE OF TYPE 2 COLLAGEN, CTX-2 ELISA KIT is meticulously crafted to meet the demands of researchers, clinicians, and professionals in the field. With its comprehensive components and user-friendly instructions, this kit offers a seamless experience, enabling efficient and streamlined analysis.

This innovative kit is specifically engineered to detect and quantify CTX-2, a crucial biomarker associated with type 2 collagen degradation. By accurately measuring CTX-2 levels, researchers and healthcare providers can gain valuable insights into the progression and severity of various collagen-related disorders, such as osteoarthritis and rheumatoid arthritis.

The HUMAN C-TELOPEPTIDE OF TYPE 2 COLLAGEN, CTX-2 ELISA KIT boasts exceptional performance, delivering rapid and precise results within a short timeframe. Its high sensitivity allows for the detection of even low concentrations of CTX-2, ensuring optimal accuracy and reliability.

Furthermore, this ELISA kit offers unparalleled convenience, as it is compatible with a wide range of human samples, including serum and plasma. Its versatility enables researchers and healthcare professionals to analyze CTX-2 levels across diverse patient populations, facilitating comprehensive investigations and informed decision-making.

In summary, the HUMAN C-TELOPEPTIDE OF TYPE 2 COLLAGEN, CTX-2 ELISA KIT is a state-of-the-art solution that empowers researchers and healthcare providers with the ability to accurately measure CTX-2 levels. With its exceptional sensitivity, reliability, and compatibility, this kit is an indispensable tool for advancing our understanding and management of collagen-related disorders.